Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG – Get Free Report) fell 4.6% during trading on Monday . Get Ascentage Pharma Group International alerts:Get Our Latest Analysis on AAPGAscentage Pharma Group International Trading Down 3.9%Institutional Trading of Ascentage Pharma Group InternationalThe firm’s 50 day simple moving average is $18.39 and its 200 day simple moving average is $22.04. UBS Group AG raised its holdings in Ascentage Pharma Group International by 149.4% during the 3rd quarter. About Ascentage Pharma Group International(Get Free Report)Ascentage Pharma Group International is a clinical?stage biopharmaceutical company focused on developing small?molecule therapeutics that modulate programmed cell death pathways, including the Bcl?2 family and the MDM2–p53 axis. Featured StoriesReceive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.